We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
-0.18%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$5.34B
AUM Growth
-$237M
Cap. Flow
-$130M
Cap. Flow %
-2.43%
Top 10 Hldgs %
17.36%
Holding
1,615
New
114
Increased
629
Reduced
604
Closed
130

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$17.6M
2
AAPL icon
Apple
AAPL
+$16.6M
3
NVDA icon
NVIDIA
NVDA
+$14.2M
4
IDXX icon
Idexx Laboratories
IDXX
+$13.7M
5
XPO icon
XPO
XPO
+$13.2M

Sector Composition

Rank Sector Weight
1 Technology 18.05%
2 Financials 11.09%
3 Healthcare 10.47%
4 Consumer Discretionary 9.45%
5 Industrials 8.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVR icon
1001
NVR
NVR
$16.5B
$523K 0.01%
109
SUNS
1002
DELISTED
SLR Senior Investment Corp. Common Stock
SUNS
$523K 0.01%
33,776
+7,186
+27% +$112K
MGIC
1003
DELISTED
Magic Software Enterprises
MGIC
$520K 0.01%
+26,000
New +$489K
WEA
1004
Western Asset Premier Bond Fund
WEA
$124M
$520K 0.01%
36,853
+1,281
+4% +$18.7K
TPTX
1005
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$520K 0.01%
7,826
+2,316
+42% +$165K
DTE icon
1006
DTE Energy
DTE
$29.5B
$519K 0.01%
4,649
-1,622
-26% -$190K
SPEM icon
1007
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.2B
$519K 0.01%
12,193
+243
+2% +$10.5K
KRUS icon
1008
Kura Sushi USA
KRUS
$559M
$518K 0.01%
+11,850
New +$549K
ACM icon
1009
Aecom
ACM
$9.32B
$516K 0.01%
8,164
+932
+13% +$59.3K
SNY icon
1010
Sanofi
SNY
$103B
$515K 0.01%
10,689
+5
+0% +$254
EWU icon
1011
iShares MSCI United Kingdom ETF
EWU
$4.14B
$513K 0.01%
15,900
+1,000
+7% +$32.8K
TEVA icon
1012
Teva Pharmaceuticals
TEVA
$40.8B
$511K 0.01%
52,395
-8,890
-15% -$83.2K
TEAF
1013
DELISTED
Ecofin Sustainable & Social Impact Term Fund
TEAF
$509K 0.01%
36,528
+37
+0.1% +$540
VISN
1014
Vistance Networks Inc
VISN
$2.65B
$507K 0.01%
37,350
-144
-0.4% -$2.48K
TNL icon
1015
Travel + Leisure Co
TNL
$4.65B
$507K 0.01%
9,304
-211
-2% -$11.5K
MGA icon
1016
Magna International
MGA
$18.7B
$506K 0.01%
6,727
-5,312
-44% -$437K
PNW icon
1017
Pinnacle West Capital
PNW
$12.2B
$506K 0.01%
6,988
+340
+5% +$26.9K
UXIN
1018
Uxin Ltd
UXIN
$308M
$505K 0.01%
1,830
LBRDK icon
1019
Liberty Broadband Class C
LBRDK
$4.89B
$498K 0.01%
2,882
-57
-2% -$10.3K
MCO icon
1020
Moody's
MCO
$82.9B
$492K 0.01%
1,386
+23
+2% +$8.67K
VTWO icon
1021
Vanguard Russell 2000 ETF
VTWO
$17.3B
$492K 0.01%
5,568
+22
+0.4% +$1.97K
ATCO
1022
DELISTED
Atlas Corp.
ATCO
$491K 0.01%
32,300
-500
-2% -$7.15K
LMND icon
1023
Lemonade
LMND
$3.73B
$490K 0.01%
7,318
-282
-4% -$22.7K
DCT
1024
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
$490K 0.01%
+11,086
New +$502K
XYLD icon
1025
Global X S&P 500 Covered Call ETF
XYLD
$3.24B
$488K 0.01%
+1,004,600
New +$49.5M

Similar funds

Oppenheimer & Co's Q3 2021 Portfolio in Review

As of Q3 2021, Oppenheimer & Co held 1,615 positions worth $5.34B, down 4.2% from $5.58B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Oppenheimer & Co's Q3 2021 filing shows 114 new, 629 increased, 604 reduced and 130 closed positions. Its largest new stake was Global X S&P 500 Covered Call ETF: 1,004,600 shares worth $488K. The largest sale was Microsoft, an estimated $17.6M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Oppenheimer & Co's largest Q3 2021 buy was Global X S&P 500 Covered Call ETF: 1,004,600 shares worth $488K.
  • Oppenheimer & Co added most to Invesco Ultra Short Duration ETF in Q3 2021, an estimated $9.29M increase.
  • Oppenheimer & Co's biggest Q3 2021 reduction was Microsoft, cutting an estimated $17.6M.
  • Oppenheimer & Co fully exited Pricesmart in Q3 2021, selling an estimated $6.18M.
  • Oppenheimer & Co's ten largest holdings make up 17% of its $5.34B portfolio in Q3 2021.
  • Oppenheimer & Co opened 114 new positions and closed 130 in Q3 2021.
  • Oppenheimer & Co's portfolio value fell 4.2% quarter-over-quarter to $5.34B.

Based on Oppenheimer & Co's 13F filing for Q3 2021, filed 12 Nov 2021.